Back

A novel autologous heart valve with growth potential

30 August 2016 (16:17 - 16:25)
Organised by:
Congress Presentation Part of: Valve repair and assist devices Aortic valve surgery ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Yoshiaki Takewa

Asahikawa Medical University, Asahikawa (Japan)

6 More presentations in this session

Presentation thumbnail
Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis
Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery
Doctor T. Wang (Auckland, NZ)
Abstract Slides
Presentation thumbnail
Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation
Mr G. Martin (Manchester, GB)
Abstract Slides
Presentation thumbnail
Metabolic syndrome affects valve-related adverse events after biological heart valve replacement
Doctor E. Angeloni (Rome, IT)
Abstract Slides
Presentation thumbnail
Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.
Doctor K. Czerwinska-Jelonkiewicz (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Valve repair and assist devices

The Event

Event poster

ESC Congress 2016

30 August 2016 16:17 CET
You may be interested in
thumbnail
Congress Presentation
Polyphenol-treatment without preceding glutaraldehyde fixation: a potential paradigm change for bioprosthetic heart valves
31 August 2024
thumbnail
Congress Presentation
Developmental changes in bicuspid aortic valve and associated aortopathy in small children
27 August 2021
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources